Immunology

Asivatrep, a TRPV1 antagonist, for the topical treatment of atopic dermatitis: Phase 3, randomized, vehicle-controlled study (CAPTAIN-AD)



http://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/9dc32139-5312-4232-bb3a-208a731745f7/fx1.jpg

Atopic dermatitis (AD) is a chronic inflammatory pruritic skin disease that flares periodically and has a high prevalence of approximately 25% in children and 10% in adults, although it depends on the countries surveyed.

  • Brunner P.M.
  • Guttman-Yassky E.
  • Leung D.Y.
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.